hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Intellectual property


International standards on intellectual property: click here

Get RSS feed of these results

Related stories and components

Article
18 March 2009

Pressure mounts over medicines regime [Canada]

Author: Fred Mwasa, Embassy [Canada]

A generic drug company plans to halt the production and shipment of cheap life-saving HIV/AIDS pills to Africa unless changes are made to Canada's Access to Medicines Regime. Canadian generic pharmaceutical company Apotex became the first company to...

Read more

Article
12 March 2009

WHO angry at seizure by Dutch of HIV drug shipment

Author: Michael Day, PharmaTimes

The World Health Organisation has condemned the Dutch Government’s “farcical” detention of HIV medication destined for Sub-Saharan Africa, which it says flouts world trade rules – and will endanger patients’ health. The WHO has been joined by other...

Read more

Article
4 March 2009

Shallow Cuts: GSK's voluntary price reductions and patent pooling are not enough

Author: Christian Barry, Centre for Applied Philosophy & Public Ethics, Australian National Univ.; Matt Peterson, Global Justice Program, MacMillan Center for Intl. & Area Studies, Yale Univ., in Global Policy Innovations [USA]

British pharmaceutical giant GlaxoSmithKline was lauded in headlines for its recent announcement that it would voluntarily act to improve access to medicines in developing countries. But will GSK's measures really enhance the health of the global poor...

Read more

Article
4 March 2009

Thai AIDS activists urge more generic drugs

Author: Dowjones Business News

Thai AIDS activists are to meet with the government to urge it not to limit a program to produce low-cost copycat drugs that has angered Western firms, a campaigner said… A post-coup military government in 2006 issued so-called compulsory licenses,...

Read more

Article
22 February 2009

Gilead’s model to enhance availability of anti-AIDS drug [India]

Author: Murali Krishnan, Sindh Today

American bio-pharmaceutical major Gilead, that has entered into generic licensing deals with 10 Indian pharma firms to distribute its HIV drug Viread, is all set to roll out its key anti-AIDS drugs at affordable prices in India and 94 other resource...

Read more

Article
17 February 2009

Letters: Big pharma's crisis of conscience

Author: Stop Aids Campaign, European Public Health Alliance, Health Action International, in Guardian [UK]

The Stop Aids Campaign welcomes the engagement of GlaxoSmithKline's chief executive, Andrew Witty, with the proposal to establish a medicines patent pool...We encourage Witty to go further and fully endorse patent pools not only for research, but for...

Read more

Article
16 February 2009
+ Español - Hide

Author: Servimedia

Los laboratorios GlaxoSmithKline (GSK) se han comprometido a poner sus fármacos al alcance de los más pobres, según aseguró Andrew Witty, su nuevo responsable, al diario británico "The Guardian". Witty anunció que GSK venderá sus medicamentos en 50 de...

Read more

Story
16 February 2009

Médecins Sans Frontières response to GlaxoSmithKline CEO proposal on access to medicines

See full story

Article
16 February 2009

MSF response to GSK patent pool proposal

Author: Michelle Childs, Director of Policy and Advocacy, Campaign for Access to Essential Medicines, Médecins Sans Frontières

Médecins Sans Frontières welcomes Mr. Witty’s recognition that patents act as a barrier to research and development and that patent pools offer new ways to stimulate research into neglected diseases. Promises now need to be turned into action... MSF...

Read more

Article
16 February 2009
+ Français - Hide

Author: Médecins Sans Frontières

Médecins Sans Frontières se réjouit de voir M. Witty reconnaître que les brevets constituent un obstacle à la recherche et au développement et que les communautés de brevets offrent de nouveaux moyens de stimuler la recherche sur les maladies négligées...

Read more